LENSAR INC 52634L108 US52634L1089 07/02/2025 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to LENSAR's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES 6534 0 FOR 6534 FOR BANKFINANCIAL CORPORATION 06643P104 US06643P1049 07/21/2025 An advisory, non-binding resolution to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES 3841 0 FOR 3841 FOR CONTEXTLOGIC INC. 21077C305 US21077C3051 07/24/2025 To approve, on an advisory basis, our executive compensation for the year ended December 31, 2024, as disclosed herein. SECTION 14A SAY-ON-PAY VOTES 3100 0 FOR 3100 FOR NEBIUS GROUP N.V. N97284108 NL0009805522 08/21/2025 Amendment of the General Guidelines for Compensation of the Board of Directors. SECTION 14A SAY-ON-PAY VOTES 3444 0 FOR 3444 FOR CELLEBRITE DI LTD. M2197Q107 IL0011794802 09/19/2025 To approve the compensation package for Thomas E. Hogan as our Chief Executive Officer. SECTION 14A SAY-ON-PAY VOTES 8000 0 FOR 8000 FOR ARES ACQUISITION CORPORATION II G33033104 KYG330331045 09/23/2025 The Incentive Plan Proposal - RESOLVED, as an ordinary resolution, that AACT's adoption of the Kodiak AI, Inc. 2025 Equity Incentive Plan, in the form attached to the proxy statement/prospectus as Annex G, be approved, ratified and confirmed in all respects. SECTION 14A SAY-ON-PAY VOTES 56360 0 FOR 56360 FOR QUANTERIX CORPORATION 74766Q101 US74766Q1013 09/29/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2884 0 AGAINST 2884 AGAINST ESSA PHARMA INC. 29668H708 CA29668H7085 10/03/2025 To consider, and, if thought advisable, to pass, an ordinary resolution to approve, on an advisory and non-binding basis, the compensation to be paid or become payable to its named executive officers that is based on or otherwise relates to the Arrangement, all as more particularly described in the Circular and Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 65921 0 FOR 65921 FOR GSR III ACQUISITION CORP. G4R103107 KYG4R1031072 10/07/2025 RESOLVED, as an ordinary resolution, the Equity Incentive Plan in the form attached to the accompanying proxy statement/prospectus as Annex G. SECTION 14A SAY-ON-PAY VOTES 21000 0 FOR 21000 FOR VISTANCE NETWORKS, INC. 20337X109 US20337X1090 10/16/2025 A proposal to approve, on an advisory, non- binding basis, certain compensation that has, will or may be paid or become payable to the Company's named executive officers in connection with the CCS Sale Transaction (the "Advisory Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 5000 0 FOR 5000 FOR LIFECORE BIOMEDICAL, INC. 514766104 US5147661046 10/29/2025 To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 2550 0 FOR 2550 FOR CORE SCIENTIFIC, INC. 21874A106 US21874A1060 10/30/2025 Core Scientific's Advisory Compensation Proposal SECTION 14A SAY-ON-PAY VOTES 3433 0 AGAINST 3433 FOR TEGNA INC. 87901J105 US87901J1051 11/18/2025 To approve, on an advisory (non-binding basis), the compensation that may be paid or become payable to TEGNA's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES 22634 0 FOR 22634 FOR AKERO THERAPEUTICS, INC 00973Y108 US00973Y1082 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES 5160 0 FOR 5160 FOR COLUMBUS CIRCLE CAPITAL CORP I G2296A109 KYG2296A1094 12/03/2025 The Incentive Plan Proposal - To approve by way of an ordinary resolution the ProCap Financial, Inc. 2025 Equity Incentive Plan, referred to as the "Incentive Plan." The form of Incentive Plan to become effective upon consummation of the Business Combination is appended to the accompanying Proxy Statement as Annex F. SECTION 14A SAY-ON-PAY VOTES 83000 0 FOR 83000 FOR WIDEOPENWEST, INC. 96758W101 US96758W1018 12/03/2025 To approve on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES 734918 0 AGAINST 734918 AGAINST THE ODP CORPORATION 88337F105 US88337F1057 12/05/2025 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid by ODP to its named executive officers that is based on or otherwise relates to the merger. SECTION 14A SAY-ON-PAY VOTES 25000 0 FOR 25000 FOR INTERNATIONAL MONEY EXPRESS, INC. 46005L101 US46005L1017 12/09/2025 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intermex's named executive officers that is based on or otherwise relates to the Merger Agreement and/or the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES 6488 0 FOR 6488 FOR VYNE THERAPEUTICS INC. 92941V308 US92941V3087 12/12/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 7500 0 FOR 7500 FOR BRAEMAR HOTELS & RESORTS INC. 10482B101 US10482B1017 12/15/2025 To obtain advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 2000 0 AGAINST 2000 AGAINST SYNLOGIC, INC. 87166L209 US87166L2097 12/15/2025 To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 2500 0 FOR 2500 FOR SYNLOGIC, INC. 87166L209 US87166L2097 12/15/2025 To approve the Synlogic, Inc. 2025 Equity Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 2500 0 FOR 2500 FOR SHUTTERSTOCK, INC. 825690100 US8256901005 12/22/2025 To cast a non-binding advisory vote to approve named executive officer compensation ("say-on- pay"). SECTION 14A SAY-ON-PAY VOTES 2103 0 FOR 2103 FOR STAAR SURGICAL COMPANY 852312305 US8523123052 01/06/2026 A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to STAAR's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES 10788 0 FOR 10788 FOR HOLOGIC, INC. 436440101 US4364401012 02/05/2026 A proposal to approve, on an advisory (non- binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger. SECTION 14A SAY-ON-PAY VOTES 21296 0 FOR 21296 FOR BRIGHTHOUSE FINANCIAL, INC. 10922N103 US10922N1037 02/12/2026 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Brighthouse Financial, Inc.'s named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES 16149 0 FOR 16149 FOR SEALED AIR CORPORATION 81211K100 US81211K1007 02/25/2026 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES 1953 0 FOR 1953 FOR AVIDITY BIOSCIENCES, INC. 05370A108 US05370A1088 02/26/2026 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. SECTION 14A SAY-ON-PAY VOTES 46820 0 FOR 46820 FOR ALEXANDER & BALDWIN, INC. 014491104 US0144911049 03/09/2026 To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. SECTION 14A SAY-ON-PAY VOTES 5000 0 FOR 5000 FOR BARK, INC. 68622E104 US68622E1047 03/25/2026 Approve, on an advisory basis, the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 85671 0 FOR 85671 FOR GOLDEN ENTERTAINMENT, INC. 381013101 US3810131017 03/31/2026 To consider and vote on the proposal to approve, on a non binding, advisory basis, the compensation that may be paid or become payable by Golden to its named executive officers in connection with the transactions contemplated by the Master Transaction Agreement (the "Advisory Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 16272 0 FOR 16272 FOR SWK HOLDINGS CORPORATION 78501P203 US78501P2039 03/31/2026 To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to SWK's named executive officers in connection with the Mergers (such proposal, the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 36762 0 FOR 36762 FOR SWK HOLDINGS CORPORATION 78501P203 US78501P2039 03/31/2026 To approve the compensation that may be paid or become payable to each member of the SWK Board in connection with the Mergers (such proposal, the "Director Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 36762 0 FOR 36762 FOR IMMERSION CORPORATION 452521107 US4525211078 04/06/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 32958 0 FOR 32958 FOR DELEK US HOLDINGS, INC. 24665A103 US24665A1034 04/20/2026 To adopt the advisory resolution approving the executive compensation program for our named executive officers as described in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 2210 0 AGAINST 2210 AGAINST DELEK US HOLDINGS, INC. 24665A103 US24665A1034 04/20/2026 To approve the 2026 Long-Term Incentive Plan as detailed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 2210 0 AGAINST 2210 AGAINST DIGITALBRIDGE GROUP, INC. 25401T603 US25401T6038 04/23/2026 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid by DigitalBridge to its named executive officers that is based on or otherwise relates to the mergers. SECTION 14A SAY-ON-PAY VOTES 6501 0 FOR 6501 FOR SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 94676 0 AGAINST 94676 AGAINST WARNER BROS. DISCOVERY, INC. 934423104 US9344231041 04/23/2026 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to WBD's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES 648 0 FOR 648 FOR CALAVO GROWERS, INC. 128246105 US1282461052 04/28/2026 The Merger-Related Compensation Proposal - A non-binding, advisory proposal to approve compensation that will or may become payable by Calavo to its named executive officers in connection with the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES 3267 0 FOR 3267 FOR YPF SOCIEDAD ANONIMA 984245100 US9842451000 04/30/2026 Waiver of the preemptive offer of shares to shareholders pursuant to Article 67 of Law No. 26,831 regarding the long-term share compensation plans for employees, through the acquisition of shares of the Company in accordance with Article 64 et. seq. of Law No. 26,831. SECTION 14A SAY-ON-PAY VOTES 1973 0 AGAINST 1973 NONE YPF SOCIEDAD ANONIMA 984245100 US9842451000 04/30/2026 Determination of advance compensation to be received by the members of the Board of Directors and the members of the Supervisory Committee for the fiscal year that began on January 1, 2026. SECTION 14A SAY-ON-PAY VOTES 1973 0 AGAINST 1973 NONE ZIM INTEGRATED SHIPPING SERVICES LTD. M9T951109 IL0065100930 04/30/2026 The Retention Bonus Proposals. To approve a one-time cash retention bonus to (a) 13 office holders of ZIM (but excluding the directors of ZIM) and (b) ZIM's Chief Executive Officer and President) of up to 12 monthly base salaries of such office holder, as shall be determined by ZIM's compensation committee and board of directors, to be paid upon the earlier of (i) the closing of the merger and (ii) the lapse of 15 months as of the date of the signing of the merger agreement (the "Retention Bonus Proposals"). SECTION 14A SAY-ON-PAY VOTES 41878 0 FOR 41878 FOR ZIM INTEGRATED SHIPPING SERVICES LTD. M9T951109 IL0065100930 04/30/2026 The Compensation Policy Proposal. To approve a new compensation policy for directors and office holders, in the form attached to the accompanying proxy statement as Annex B, for a period of three years from the date of the ZIM special general meeting (the "Compensation Policy Proposal"). SECTION 14A SAY-ON-PAY VOTES 41878 0 FOR 41878 FOR CLEAR CHANNEL OUTDOOR HOLDINGS, INC. 18453H106 US18453H1068 05/12/2026 A proposal to approve, on an advisory, non- binding basis, the specified compensation that will or may be paid or may become payable to the Company's named executive officers in connection with the Merger (the "Advisory Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 18600 0 FOR 18600 FOR ENHABIT, INC. 29332G102 US29332G1022 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES 2000 0 FOR 2000 FOR BURFORD CAPITAL LIMITED G17977110 GG00BMGYLN96 05/13/2026 To authorize the audit committee of the Board of Directors to agree to the compensation of the Company's external auditor. (Ordinary Resolution) SECTION 14A SAY-ON-PAY VOTES 48826 0 FOR 48826 FOR BURFORD CAPITAL LIMITED G17977110 GG00BMGYLN96 05/13/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement for the 2026 annual general meeting of shareholders under "Executive compensation", including the compensation discussion and analysis, the compensation tables and the related narrative discussion included therein ("Say-on-Pay"). (Ordinary Resolution) SECTION 14A SAY-ON-PAY VOTES 48826 0 FOR 48826 FOR CORBUS PHARMACEUTICALS HOLDINGS, INC. 21833P301 US21833P3010 05/13/2026 Approval of an amendment to the Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares to 5,000,000 shares. SECTION 14A SAY-ON-PAY VOTES 44840 0 FOR 44840 FOR CORBUS PHARMACEUTICALS HOLDINGS, INC. 21833P301 US21833P3010 05/13/2026 Approval, on an advisory basis, of the executive compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 44840 0 FOR 44840 FOR CORBUS PHARMACEUTICALS HOLDINGS, INC. 21833P301 US21833P3010 05/13/2026 To vote, on an advisory basis, on how often the Company will conduct an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 44840 0 1 YEAR 44840 NONE SITE CENTERS CORP. 82981J851 US82981J8514 05/13/2026 Approval, on an advisory basis, of the compensation of the Company's Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 9836 0 FOR 9836 FOR TRILOGY METALS INC. 89621C105 CA89621C1059 05/13/2026 To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 59542 0 FOR 59542 FOR DISTRIBUTION SOLUTIONS GROUP, INC. 520776105 US5207761058 05/14/2026 Approval, on an advisory basis, of the compensation of our named executive officers (say-on-pay) SECTION 14A SAY-ON-PAY VOTES 15489 0 FOR 15489 FOR DISTRIBUTION SOLUTIONS GROUP, INC. 520776105 US5207761058 05/14/2026 Approval of DSG's Amended and Restated 2026 Equity Compensation Plan SECTION 14A SAY-ON-PAY VOTES 15489 0 FOR 15489 FOR FULL HOUSE RESORTS, INC. 359678109 US3596781092 05/14/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 903985 0 FOR 903985 FOR MEREO BIOPHARMA GROUP PLC 589492107 US5894921072 05/14/2026 That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis. SECTION 14A SAY-ON-PAY VOTES 329200 0 AGAINST 329200 AGAINST PROTHENA CORPORATION PLC G72800108 IE00B91XRN20 11/19/2025 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES 425293 0 AGAINST 425293 AGAINST ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Approval of the Third Amended and Restated 2023 Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 1000 0 FOR 1000 FOR ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1000 0 FOR 1000 FOR MARRIOTT VACATIONS WORLDWIDE CORPORATION 57164Y107 US57164Y1073 05/15/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 2000 0 FOR 2000 FOR MARRIOTT VACATIONS WORLDWIDE CORPORATION 57164Y107 US57164Y1073 05/15/2026 Approval of the Second Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 2000 0 FOR 2000 FOR MACROGENICS, INC. 556099109 US5560991094 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES 21500 0 AGAINST 21500 AGAINST MACROGENICS, INC. 556099109 US5560991094 05/19/2026 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES 21500 0 AGAINST 21500 AGAINST PAYPAL HOLDINGS, INC. 70450Y103 US70450Y1038 05/19/2026 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES 1973 0 FOR 1973 FOR MTY FOOD GROUP INC. 55378N107 CA55378N1078 05/20/2026 On an advisory basis, to accept the Board's approach to executive compensation disclosed in the Information Circular. SECTION 14A SAY-ON-PAY VOTES 1900 0 AGAINST 1900 AGAINST LEGGETT & PLATT, INCORPORATED 524660107 US5246601075 05/21/2026 An advisory vote to approve named executive officer compensation as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES 177522 0 FOR 177522 FOR ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan; SECTION 14A SAY-ON-PAY VOTES 353501 0 FOR 353501 FOR ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and SECTION 14A SAY-ON-PAY VOTES 353501 0 FOR 353501 FOR EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. SECTION 14A SAY-ON-PAY VOTES 3251 0 FOR 3251 FOR EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 3251 0 FOR 3251 FOR ODYSSEY MARINE EXPLORATION, INC. 676118201 US6761182012 06/01/2026 To obtain non-binding advisory approval of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 5126 0 FOR 5126 FOR TECTONIC THERAPEUTIC, INC. 878972108 US8789721086 06/08/2026 Advisory approval of the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 6000 0 AGAINST 6000 AGAINST CABALETTA BIO, INC. 12674W109 US12674W1099 06/09/2026 To approve an amendment to the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 1000 0 AGAINST 1000 AGAINST CABALETTA BIO, INC. 12674W109 US12674W1099 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1000 0 AGAINST 1000 AGAINST CAESARS ENTERTAINMENT, INC. 12769G100 US12769G1004 06/09/2026 ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES 3287 0 FOR 3287 FOR QUANTERIX CORPORATION 74766Q101 US74766Q1013 09/29/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 2376 0 FOR 2376 FOR QUANTERIX CORPORATION 74766Q101 US74766Q1013 09/29/2025 To approve the amendment and restatement of the Company's 2017 Employee, Director and Consultant Equity Incentive Plan SECTION 14A SAY-ON-PAY VOTES 2376 0 FOR 2376 FOR WARNER BROS. DISCOVERY, INC. 934423104 US9344231041 04/23/2026 To vote on an advisory resolution to approve the 2025 compensation of Warner Bros. Discovery, Inc.'s named executive officers, commonly referred to as a "Say-on-Pay" vote. SECTION 14A SAY-ON-PAY VOTES 33448 0 FOR 33448 FOR ALIGHT, INC. 01626W101 US01626W1018 06/10/2026 To approve, on an advisory (non-binding) basis, the 2025 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 247482 0 FOR 247482 FOR APARTMENT INVESTMENT AND MANAGEMENT CO. 03748R747 US03748R7474 06/10/2026 To conduct an advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 90000 0 FOR 90000 FOR KENNEDY-WILSON HOLDINGS, INC. 489398107 US4893981070 06/10/2026 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Kennedy Wilson to its named executive officers in connection with the transactions contemplated by the Merger Agreement (the "Advisory Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 97000 0 ABSTAIN 97000 AGAINST KIORA PHARMACEUTICALS, INC. 49721T507 US49721T5074 06/10/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 9000 0 AGAINST 9000 AGAINST KIORA PHARMACEUTICALS, INC. 49721T507 US49721T5074 06/10/2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to increase the maximum number of shares authorized for issuance thereunder by 1,500,000 shares. SECTION 14A SAY-ON-PAY VOTES 9000 0 AGAINST 9000 AGAINST NKARTA, INC. 65487U108 US65487U1088 06/10/2026 Advisory approval of the compensation paid to the company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 68000 0 AGAINST 68000 AGAINST NKARTA, INC. 65487U108 US65487U1088 06/10/2026 Advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES 68000 0 ABSTAIN 68000 NONE UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 6909 0 FOR 6909 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 6909 0 1 YEAR 6909 NONE UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 6909 0 FOR 6909 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 9484 0 FOR 9484 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 9484 0 1 YEAR 9484 NONE UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 9484 0 FOR 9484 FOR XPEL INC 98379L100 US98379L1008 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1316 0 AGAINST 1316 AGAINST YEXT, INC. 98585N106 US98585N1063 06/10/2026 Approve, on an advisory basis, the compensation of Yext, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 64406 0 FOR 64406 FOR YEXT, INC. 98585N106 US98585N1063 06/10/2026 Approve the amended, restated and extended Yext, Inc. 2016 Equity Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 64406 0 FOR 64406 FOR JANUX THERAPEUTICS, INC. 47103J105 US47103J1051 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 106293 0 AGAINST 106293 AGAINST PLIANT THERAPEUTICS, INC. 729139105 US7291391057 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES 225000 0 AGAINST 225000 AGAINST PRIORITY TECHNOLOGY HOLDINGS, INC. 74275G107 US74275G1076 06/11/2026 To approve Amendment 2 to Priority Technology Holdings, Inc. 2018 Equity Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 52020 0 AGAINST 52020 AGAINST PRIORITY TECHNOLOGY HOLDINGS, INC. 74275G107 US74275G1076 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 52020 0 AGAINST 52020 AGAINST WHITEHAWK THERAPEUTICS, INC. 00032Q104 US00032Q1040 06/11/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES 5000 0 AGAINST 5000 AGAINST ABEONA THERAPEUTICS INC. 00289Y206 US00289Y2063 06/12/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 60000 0 AGAINST 60000 AGAINST ABEONA THERAPEUTICS INC. 00289Y206 US00289Y2063 06/12/2026 To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. SECTION 14A SAY-ON-PAY VOTES 60000 0 AGAINST 60000 AGAINST THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 19590 0 AGAINST 19590 AGAINST WW INTERNATIONAL, INC. 98262P200 US98262P2002 06/12/2026 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 16800 0 AGAINST 16800 AGAINST IMAGENEBIO, INC. 45175G207 US45175G2075 06/16/2026 To approve an amendment and restatement of the Company's 2025 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the 2025 Plan by 850,000 shares and include in the calculation of the annual automatic share reserve increase shares of common stock issuable upon conversion or exercise of convertible preferred stock and prefunded warrants. SECTION 14A SAY-ON-PAY VOTES 20090 0 AGAINST 20090 AGAINST 4D MOLECULAR THERAPEUTICS, INC. 35104E100 US35104E1001 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES 8771 0 AGAINST 8771 AGAINST ADICET BIO, INC. 007002108 US0070021086 12/19/2025 To ratify, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 52248 0 AGAINST 52248 AGAINST BICYCLE THERAPEUTICS PLC 088786108 US0887861088 06/17/2026 To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 221313 0 AGAINST 221313 AGAINST FORWARD AIR CORPORATION 34986A104 US34986A1043 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the named executive officers (the "say on pay vote"). SECTION 14A SAY-ON-PAY VOTES 66632 0 AGAINST 66632 AGAINST FORWARD AIR CORPORATION 34986A104 US34986A1043 06/17/2026 To approve an amendment to the 2025 Omnibus Incentive Compensation plan to increase number of shares of common stock authorized for issuance thereunder. SECTION 14A SAY-ON-PAY VOTES 66632 0 AGAINST 66632 AGAINST STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 70000 0 AGAINST 70000 AGAINST STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 70000 0 AGAINST 70000 AGAINST ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 51500 0 AGAINST 51500 AGAINST ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 51500 0 ABSTAIN 51500 NONE ATEA PHARMACEUTICALS, INC. 04683R106 US04683R1068 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 2 0 AGAINST 2 AGAINST CADIZ, INC. 127537207 US1275372076 06/18/2026 Advisory vote on executive compensation as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES 32486 0 FOR 32486 FOR HARROW INC. 415858109 US4158581094 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 1936 0 FOR 1936 FOR PAGERDUTY, INC. 69553P100 US69553P1003 06/18/2026 To conduct an advisory, non-binding vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 16460 0 FOR 16460 FOR REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say- on-Pay"). SECTION 14A SAY-ON-PAY VOTES 10022 0 FOR 10022 FOR SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 653 0 FOR 653 FOR SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan. SECTION 14A SAY-ON-PAY VOTES 653 0 FOR 653 FOR GREEN DOT CORPORATION 39304D102 US39304D1028 06/23/2026 To approve, on an advisory (non-binding) basis, the transaction-related compensation payments that will or may be paid to named executive officers of Green Dot in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. SECTION 14A SAY-ON-PAY VOTES 165669 0 FOR 165669 FOR SPERO THERAPEUTICS, INC. 84833T103 US84833T1034 06/23/2026 To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 41 0 FOR 41 FOR SPERO THERAPEUTICS, INC. 84833T103 US84833T1034 06/23/2026 To approve adoption of the 2026 Spero Therapeutics, Inc. Stock Incentive Plan. SECTION 14A SAY-ON-PAY VOTES 41 0 FOR 41 FOR WILLIS LEASE FINANCE CORPORATION 970646105 US9706461053 06/23/2026 Cast an advisory vote to approve the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 653 0 AGAINST 653 AGAINST ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 176590 0 AGAINST 176590 AGAINST C4 THERAPEUTICS, INC. 12529R107 US12529R1077 06/24/2026 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 8000 0 AGAINST 8000 AGAINST C4 THERAPEUTICS, INC. 12529R107 US12529R1077 06/24/2026 To approve an amendment to our 2020 Stock Option and Incentive Plan to amend the evergreen provision to include any outstanding pre-funded warrants in the total number of shares of common stock that are issued and outstanding as of each December 31. SECTION 14A SAY-ON-PAY VOTES 8000 0 AGAINST 8000 AGAINST SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 50000 0 ABSTAIN 50000 AGAINST BARNWELL INDUSTRIES, INC. 068221100 US0682211000 06/29/2026 The approval of amendments to the 2018 Equity Incentive Plan (the "2018 Plan") to (i) increase the number of shares available for issuance under the 2018 Plan from 1,600,000 to 3,080,000, and (ii) increase the individual annual share limits set forth in Section 4.2 of the 2018 Plan. SECTION 14A SAY-ON-PAY VOTES 10645 0 FOR 10645 FOR BARNWELL INDUSTRIES, INC. 068221100 US0682211000 06/29/2026 An advisory (non-binding) vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 10645 0 FOR 10645 FOR BARNWELL INDUSTRIES, INC. 068221100 US0682211000 06/29/2026 An advisory (non-binding) vote on the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 10645 0 1 YEAR 10645 NONE